期刊文献+

外周血炎性因子IL-10、IL-32与帕金森病认知功能障碍及非运动症状的相关性

Correlation between peripheral inflammatory cytokines IL-10 and IL-32 and cognitive dysfunction and non-motor symptoms of Parkinson's disease
原文传递
导出
摘要 目的对帕金森病患者与健康对照者进行外周血IL-10、IL-32水平测定以及认知功能及非运动症状的评估,分析IL-10、IL-32水平与帕金森病认知功能障碍及非运动症状之间的相关性。方法选取2022年1月—2023年10月于蚌埠医科大学第一附属医院就诊的帕金森病患者60例作为PD组,健康体检者60例作为对照组。采用ELISA法检测2组受试者血清IL-10、IL-32浓度水平;使用简易智力状态检查表和运动症状评价量表评估2组研究对象的认知功能及非运动症状;使用秩相关法分析外周血炎性因子IL-10、IL-32与帕金森病认知功能障碍及非运动症状的相关性。结果PD组患者外周血中IL-10水平[136.60(117.05,169.70)pg/mL]高于对照组[110.90(92.15,129.50)pg/mL,P<0.01],PD组IL-32水平[32.35(28.83,37.68)pg/mL]高于对照组[21.80(20.60,23.35)pg/mL,P<0.01];PD患者外周血IL-10水平与MMSE[(20.68±6.33)分]评分及NMSS[(103.17±11.25)分]评分均呈正相关(P<0.01),PD患者外周血IL-32水平与MMSE评分及NMSS评分均呈正相关(P<0.01)。结论PD患者外周血中炎性因子IL-10、IL-32水平较健康对照者高,并且与帕金森病认知功能障碍及非运动症状有密切的相关性。 Objective To analyze the correlation between the levels of IL-10 and IL-32 and the cognitive dysfunction and non-motor symptoms of Parkinson's disease(PD),we measured levels of IL-10 and IL-32 in the peripheral blood of Parkinson's disease patients and healthy controls and evaluated their cognitive function and non-motor symptoms.Methods Sixty patients with Parkinson's disease in the First Affiliated Hospital of Bengbu Medical University from January 2022 to October 2023 were selected as the observation group,and 60 healthy subjects were selected as the control group.Serum concentrations of IL-10 and IL-32 in the two groups were detected by ELISA.The cognitive function and non-motor symptoms of the two groups were evaluated using the simple mental state checklist and the motor symptom assessment scale.The correlation between peripheral inflammatory factors IL-10 and IL-32 and cognitive dysfunction and non-motor symptoms of Parkinson's disease was analyzed by hierarchical correlation method.Results The level of IL-10 in the peripheral blood of PD group was[136.60(117.05,169.70)pg/mL],which was higher than that of the control group[110.90(92.15,129.50)pg/mL,P<0.01].The level of IL-32 in the PD group was[32.35(28.83,37.68)pg/mL],which was higher than that in the control group[21.80(20.60,23.35)pg/mL,P<0.01].The level of IL-10 in the peripheral blood of PD patients was positively correlated with MMSE score(20.68±6.33)and NMSS score(103.17±11.25,P<0.01).The level of IL-32 in the peripheral blood in PD patients was also positively correlated with MMSE score and NMSS score(P<0.01).Conclusion The levels of inflammatory factors IL-10 and IL-32 in the peripheral blood of PD patients were higher than those of healthy controls,and were closely correlated with cognitive dysfunction and non-motor symptoms of PD.
作者 吴梦琦 时鹏 李倩倩 田家玲 李强 WU Mengqi;SHI Peng;LI Qianqian;TIAN Jialing;LI Qiang(Department of Neurology,the First Affiliated Hospital of Bengbu Medical University,Bengbu,Anhui 233004,China)
出处 《中华全科医学》 2024年第8期1325-1327,1363,共4页 Chinese Journal of General Practice
基金 安徽省临床医学转化项目(202304295107020075) 蚌埠医学院自然科学基金重点项目(2021byzd049) 蚌埠医学院研究生科研创新计划项目(Byycx22119)。
关键词 帕金森病 白介素-10 白介素-32 认知功能障碍 非运动症状 Parkinson's disease IL-10 IL-32 Cognitive dysfunction Non-motor symptoms
  • 相关文献

参考文献2

二级参考文献39

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 3Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 4Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 5Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 6Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 7Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 8Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 9Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.
  • 10Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory functiondistinguishes vascular parkinsonism from Parkinson's disease[ J].J Neurol Neurosurg Psychiatry, 2004, 75(12) : 1749-1752.

共引文献1162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部